Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


Your body is 3D, why is your cell culture not?

27 Sep 2013 - 27 Sep 2013 - Webinar



Bookmark and Share


3D cell-based applications close the gap between conventional in-vitro approaches and in vivo animal model research. By automating the 3D cell culture process and assay detection in a microplate based format, this significantly shortens development time of new drug candidates as well as offering more reliable statistical results.   

Tecan will present solutions for 3D cell culture systems using the Alvetex (Reinnervate), RAFT (TAP Biosystems)  scaffold based, and GravityPlus (InSphero) scaffold-free technology. In particular, automating a 3D cell culture system with the Freedom EVO® liquid handling platform offers a simple and reliable approach for cultivation, and the Infinite M-200 PRO multi-detection reader with its Optimal Read function in conjunction with the patent pending Gas Control Module (GCMTM) offers an excellent solution for acute and chronic toxicity tests, as well as multiplexed assays in cancer research.

Presenter:
Christian Oberdanner, PhD
Application Specialist Sales & Marketing, Tecan Austria GmbH

Christian Oberdanner, PhD, studied Molecular- and Cell-Biology at the University of Salzburg, Austria. In his doctoral thesis he focused on Reactive Oxygen Species-mediated apoptosis induction in photodynamic cancer therapy. 

Christian started to work for Tecan Austria as an external scientific consultant already during his last year at University. After his graduation he joined Tecan as Application Specialist in the department for research and development but quickly changed to the sales and marketing department. His expertise is on applications for Tecan’s multimode readers and microplate washers but he is also contributing to new product developments as a Junior Product Manager.


Further information
Scientific News
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!